Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

National Academy of Medicine (NAM) Webinar: February 13, 4–5 pm ET

The NAM webinar will introduce the Action Collaborative on Countering the U.S. Opioid Epidemic, which comprises government, communities, health systems, provider groups, payers, industry, nonprofits, academia, and more. For more information and to register .

Statement from FDA Commissioner Scott Gottlieb, MD, on Unprecedented New Efforts to Support Development of Over-the-Counter Naloxone to Help Reduce Opioid Overdose Deaths

To encourage drug companies to enter the OTC market and increase access to naloxone, the FDA took an unprecedented step of developing a model Drug Facts label (DFL) with easy-to-understand pictograms on how to use the drug. Full story.
Topics:

Study of Colorado’s Efforts to Reverse Opioid Epidemic

The American Medical Association (AMA), Colorado Medical Society (CMS) and Manatt Health released a report today that shows Colorado has implemented meaningful reforms in response to the opioid epidemic though further steps are needed to save even more lives. Full story.

National Academy of Medicine Workshop on Prescribing Opioids for Acute Pain

NASEM will host two public workshops to gather information and guide its work in drafting clinical practice guidelines for prescribing opioids for acute pain. Register for the first webinar on February 4th .

Pain Management Task Force Calls for Patient-Centered Treatment of Pain

The HHS Pain Management Best Practices Inter-Agency Task Force has released a draft report calling for individualized, patient-centered pain management to improve the lives of millions of individuals who experience acute and chronic pain. Members of the public have 90 days to provide comments on the report's recommendations. The Academy is preparin...
Continue reading

U.S. FDA Panel Votes for Prescribing Naloxone with Opioids

An advisory panel to the U.S. Food and Drug Administration recommended prescribing the opioid overdose reversal drug, naloxone, with addictive painkilllers. Full story .

Study of Pennsylvania Commonwealth Efforts to Reverse Opioid Epidemic

The American Medical Association (AMA), Pennsylvania Medical Society (PAMED) and Manatt Health released the first in a series of studies of state responses to the opioid epidemic. Full story .

US: Fears of Prescribing Hurt Chronic Pain Patients

Federal and state government efforts to reduce prescription opioids are inadvertently harming chronic pain patients in the United States, Human Rights Watch said in a new report. Full Story .

Treating America's Pain: Unintended Victims of the Opioid Crackdown

A three-part Fox News Series examines the nation's struggle to address a crippling opioid crisis, and the unintended victims left in its wake: Part 1: The Suicides Part 2: The Doctors Part 3: The Solutions  

AAPM Fights Misapplication of CDC Guideline Through AMA

Your AAPM delegates joined other pain and palliative medicine societies to rally the AMA House of Delegates to adopt a policy opposing the misuse of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. Read about this and other recent efforts to advocate for pain medicine through the AMA.